US Stock Market Move | Initial decline in the stock price of Photonics Communications, Ciena (CIEN.US) fell by nearly 21% after the earnings report.
On Thursday, the share price of Guantong Communications fell at the beginning of the trading session.
On Thursday, the stock of Ciena Corp fell at the opening, with Ciena (CIEN.US) dropping nearly 21% after earnings, POET Technologies (POET.US) down nearly 10%, Corning Inc (GLW.US) falling over 7%, Lumentum (LITE.US) dropping close to 7%, Marvell Technology, Inc. (MRVL.US), Nokia Oyj Sponsored ADR (NOK.US) falling over 6%. On the news front, Ciena reported second quarter revenue of $1.57 billion, a year-on-year increase of 40%; adjusted EPS was $1.64, a year-on-year increase of 290%. Analysts pointed out that Ciena's third quarter revenue guidance is in the range of $1.575 billion to $1.675 billion, with the median below the market's heightened expectations, suggesting that the full-year guidance of $6.3 billion did not bring any major surprises.
Related Articles

US Stock Market Move | Cross-border securities business rectification collectively landed, UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) increased by over 2% in early trading.

"Wood Sister" Wood aggressively increased their holdings in Alphabet Inc. Class C, a subsidiary of Alphabet Inc. (GOOGL.US), with a total purchase of over 260,000 shares across four funds.

US Stock Market Move | Increasing investment in the layout of pharmaceutical production capacity in the United States, Eli Lilly (LLY.US) surged over 5% in early trading.
US Stock Market Move | Cross-border securities business rectification collectively landed, UP Fintech Holding Ltd. Sponsored ADR Class A (TIGR.US) increased by over 2% in early trading.

"Wood Sister" Wood aggressively increased their holdings in Alphabet Inc. Class C, a subsidiary of Alphabet Inc. (GOOGL.US), with a total purchase of over 260,000 shares across four funds.

US Stock Market Move | Increasing investment in the layout of pharmaceutical production capacity in the United States, Eli Lilly (LLY.US) surged over 5% in early trading.






